Mesoblast Limited (MESO) vs Sarepta Therapeutics, Inc. (SRPT)
Mesoblast Limited and Sarepta Therapeutics, Inc. are both Biotechnology companies. Mesoblast Limited and Sarepta Therapeutics, Inc. are of similar size ($2.0B and $2.0B). Sarepta Therapeutics, Inc. grew revenue faster over the last twelve months: −20.4% against −26.5%. Sarepta Therapeutics, Inc. has the higher net margin (−6.93% vs −1,091.7%) and the lower return on invested capital (−5.64% vs 0.00%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 10 and Mesoblast Limited on 8.
Valuation
Profitability
| Metric | MESO | SRPT | Biotechnology median |
|---|---|---|---|
| Gross margin | (269.72%) | 59.09% | 65.16% |
| Operating margin | (826.28%) | (7.26%) | 0.00% |
| Net margin | (1,091.71%) | (6.93%) | 0.00% |
| Free cash flow margin | 0.00% | 3.80% | 0.00% |
| Return on equity | 0.00% | (9.48%) | (57.72%) |
| Return on assets | 0.00% | (3.98%) | (49.22%) |
| Return on invested capital | 0.00% | (5.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack